Senescent microglia accumulate in aging brains and drive neuroinflammation; targeted senotherapeutic interventions suppress this state and restore microglial function. This represents a mechanistic pathway to reduce age-related cognitive decline through cellular state modification rather than broad immunosuppression.
Key Points
- Senescent microglia accumulate specifically in white matter with age
- Disease-associated microglial phenotype drives neuroinflammation and dysfunction
- Senotherapeutics selectively suppress senescent state, restoring normal function
Longevity Analysis
Microglial senescence emerges as a treatable driver of brain aging, not an inevitable consequence of time. Rather than accepting age-related cognitive decline as fixed, this work identifies a specific cellular state amenable to intervention—shifting the paradigm from managing symptoms to addressing root dysfunction. The ability to distinguish and selectively target senescent from healthy microglia opens precision approaches to preserving neural resilience, consciousness clarity, and cognitive reserve across the lifespan. This moves beyond broad anti-inflammatory strategies toward state-specific cellular restoration.
Original published by Nature Aging.